You're reading the free version. Trader adds the live tape and alerts.
Start tracking
XENE Award Disclosure
Svoronos Dawn · SEC Form 4 · Filed Jun 3, 2026
Award
Calculated transaction value
$0
Svoronos Dawn Director
XENE
Transaction date
Jun 3, 2026
Public filing date
Jun 3, 2026
Filing lag
Filed same day
XENE daily price context
Close on/before transaction
$53.46
Jun 3, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Share Option (Right to Buy) on Common Shares
- Quantity / price
- 10,507 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-256118
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$75.63K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Xenon Pharmaceuticals Inc. XENE Current | Award | Jun 3, 2026 | $0 |
| Xenon Pharmaceuticals Inc. XENE | Award | Jun 3, 2026 | $0 |
| Xenon Pharmaceuticals Inc. XENE | Exercise | Jun 1, 2026 | Not reported |
| Xenon Pharmaceuticals Inc. XENE | Disposition | Jun 1, 2026 | $75.63K |
| Xenon Pharmaceuticals Inc. XENE | Exercise | Jun 1, 2026 | $0 |